Summary
Traditionally treated with an open surgical approach to stabilize vertebral bones and joints, spinal fusion is one of a number of surgical procedures that has begun the shift towards less invasive surgical techniques. With the advent of advanced imaging technologies, minimally invasive techniques have emerged as a solution to many of the disadvantages of traditional spinal fusion. Shorter operation time, less trauma to the patient’s anatomy, and faster return to motion are benefits of minimally invasive spine (MIS) surgery that, coupled with the global aging population and continued advancements in navigational technology, will propel its adoption. However, the growth of motion preserving solutions, cost-containment pressures in European healthcare systems, and low physician and patient awareness in emerging markets threaten the widespread adoption of this approach.
This report provides up-to-date information and in-depth analysis on the key players that shape the global MIS market. This includes an analysis of company profiles, industry trends, and corporate strategy. The report identifies the unmet needs in the market while providing an understanding of physicians’ perceptions and decision-making processes in using and evaluating the adoption of different types of devices.
*This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase.
Scope
- Investigation of current and future market competition in the MIS market.
- Competitive Assessment including product profiles.
- Coverage of key market players and company profiles, including business description, financial overview, product portfolio assessment, and SWOT analysis.
- Strategic Assessment of the market through market impact analysis, future market scenario, and company analysis.
Reasons to buy
- Gain a high level view of the trends shaping and driving the MIS market.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Drive revenues, formulate effective sales and marketing strategies, and gain in-depth understanding of the competitive landscape.
- Take a comprehensive look at the market’s device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
Companies Mentioned
DePuy Synthes (JNJ)
Globus Medical
Medtronic
NuVasive
Stryker
Zimmer Biomet
'
1 Table of Contents
1 Table of Contents 1
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 11
2.1 Catalyst 11
2.2 Related Reports 11
3 Competitive Assessment 26
3.1 Market Share Analysis 26
3.1.1 Global Overview 26
3.1.2 North America 27
3.1.3 Europe 28
3.1.4 Asia-Pacific 29
3.1.5 South America 30
3.1.6 Middle East and Africa 31
3.2 Key Companies and Product Profiles 32
3.2.1 DePuy Synthes (JNJ) 32
3.2.2 Globus Medical 34
3.2.3 Medtronic 35
3.2.4 NuVasive 36
3.2.5 Stryker 38
3.2.6 Zimmer Biomet 39
3.2.7 Other Players 41
3.3 Clinical Trials to Watch 44
3.4 Pipeline Products Assessment 46
4 Appendix 80
4.1 Bibliography 80
4.2 Abbreviations 84
4.3 Methodology 87
4.3.1 Overview 87
4.3.2 Coverage 87
4.3.3 Secondary Research 88
4.4 Forecasting Methodology 88
4.5 Primary Research Summary 89
4.6 About the Authors 90
4.6.1 Jennifer Ryan, Orthopedic Analyst, Medical Devices 90
4.6.2 Linda Tian, MSc, Managing Analyst, Medical Devices 90
4.6.3 Tyler Fletcher, Global Head of Medical Devices 90
4.6.4 About GlobalData 91
4.7 Contact Us 91
4.8 Disclaimer 91
1.1 List of Tables
Table 1: DePuy Synthes - SWOT Analysis 33
Table 2: DePuy Synthes - Key Marketed Products Assessment 33
Table 3: Globus Medical - SWOT Analysis 34
Table 4: Globus Medical - Key Marketed Products Assessment 34
Table 5: Medtronic - SWOT Analysis 36
Table 6: Medtronic - Key Marketed Products Assessment 36
Table 7: NuVasive - SWOT Analysis 37
Table 8: NuVasive - Key Marketed Products Assessment 37
Table 9: Stryker - SWOT Analysis 38
Table 10: Stryker - Key Marketed Products Assessment 39
Table 11: Zimmer Biomet - SWOT Analysis 40
Table 12: Zimmer Biomet - Key Marketed Products Assessment 40
Table 13: Other Players Assessment 41
Table 14: Clinical Trials to Watch 44
Table 15: Pipeline Products Assessment 46
1.2 List of Figures
Figure 1: Minimally Invasive Spine Primary Research Participants, by Region 89
